Vaginosis/Vaginitis Panel by NAAT, Vaginal Swab : 1015864

Test Code
BVTRICHCAG or 1015864

Alias/See Also
Trichomonas vaginalis; Candida albicans; Candida glabrata; Lactobacillus species; Gardnerella vaginalis; Atopobium vaginae

CPT Codes
87481x2, 87798, 87661, 87511

This test includes the following individual tests:

Test Name                                                                                                         Order Code            Interface Code  
Bacterial Vaginosis by Multiplex Quantitative real time PCR, Vaginal Swab                  BVMOL                  1005024
Trichomonas vaginalis RNA by TMA                                                                       TRICHV                  1003711
Candida albicans and Candida glabrata by Qualitative PCR                                       CAGPCR                 1004189

Vaginal Specimens: APTIMA Vaginal Swab Collection Kit (Client Supply # B30079)
1. Collect vaginal fluid sample using the Gen-Probe APTIMA vaginal swab kit by contacting the swab to the lower third of the vaginal wall and rotating the swab for 10 to 30 seconds to absorb fluid.
2. Immediately place the swab into the transport tube and carefully break the swab shaft against the side of the tube.
3. Tightly screw on the cap.
4. NOTE: The APTIMA Vaginal Swab Collection Kit is the only Collection Kit approved for vaginal specimens. DO NOT use the APTIMA Combo 2 Unisex Swab Collection Kit for collecting vaginal specimens.

Transport Container
Refer to specimen collection instructions for submission in Aptima transport tube.

Transport Temperature

Specimen Stability
Aptima Vaginal Swab: Ambient: 60 days; Refrigerated: 60 days; Frozen: Unacceptable

Nucleic acid amplification testing (NAAT)

Setup Schedule
Monday & Wednesday & Friday

Report Available
3-5 days

Reference Range
Trichomonas vaginalis, Candida albicans and Candida glabrata : Target Not Detected (TND)

Bacterial vaginosis: Total DNA ≥ 106 copies/mL, Lactobacillus spp. DNA no less than Total DNA
and G. vaginalis and A. vaginae < Lactobacillus spp. DNA

Clinical Significance
Common symptoms include vaginal discharge, vulvovaginal irritation, and/or dysuria. However, recurrent and/or untreated infections can result in ectopic pregnancy, infertility, and the possible risk of physical and developmental disabilities in fetus, including fetal death in few cases. Healthcare providers must assess the risk of infections and provide counseling for prevention and treatment for all women of childbearing age. Nucleic acid amplification testing (NAAT) is analytically more sensitive than culture and antigen detection methods and is recommended for screening and prevention. The bacterial vaginosis/ vaginitis panel provides efficient and accurate testing solutions for bacterial vaginosis and vaginitis from yeast and trichomonas infections using molecular techniques with well-established clinical correlation from a single swab collection. It detects Bacterial vaginosis, Trichomonas vaginalis and Candida albicans and C glabrata. Bacterial vaginosis is detected by quantitative ratios of specific anaerobic microflora such as Gardrenella vaginalis and Atopobium vaginae in relation to Lactobacillus spp., which are highly sensitive and specific for the diagnosis of bacterial vaginosis and is associated with disease recurrence. This helps physicians to get multiple actionable results in a timely manner using clinically-proven technologies.

Performing Laboratory
med fusion

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.